SAPONARO, Giulia
 Distribuzione geografica
Continente #
NA - Nord America 3.646
EU - Europa 2.984
AS - Asia 1.410
SA - Sud America 294
Continente sconosciuto - Info sul continente non disponibili 57
AF - Africa 37
OC - Oceania 4
Totale 8.432
Nazione #
US - Stati Uniti d'America 3.566
FI - Finlandia 1.929
SG - Singapore 426
CN - Cina 398
DE - Germania 248
BR - Brasile 239
IT - Italia 213
VN - Vietnam 204
PL - Polonia 162
HK - Hong Kong 111
TR - Turchia 101
GB - Regno Unito 87
UA - Ucraina 86
SE - Svezia 63
RU - Federazione Russa 55
CA - Canada 54
FR - Francia 48
IN - India 40
BD - Bangladesh 27
JP - Giappone 22
AR - Argentina 21
BE - Belgio 21
ZA - Sudafrica 21
MX - Messico 19
ID - Indonesia 17
IQ - Iraq 16
ES - Italia 15
NL - Olanda 15
CO - Colombia 10
AT - Austria 9
EC - Ecuador 8
CZ - Repubblica Ceca 7
PK - Pakistan 6
UZ - Uzbekistan 6
AE - Emirati Arabi Uniti 5
UY - Uruguay 5
AU - Australia 4
CL - Cile 4
KR - Corea 4
TN - Tunisia 4
TW - Taiwan 4
BG - Bulgaria 3
EG - Egitto 3
HU - Ungheria 3
IL - Israele 3
KE - Kenya 3
LT - Lituania 3
SA - Arabia Saudita 3
TH - Thailandia 3
AZ - Azerbaigian 2
BO - Bolivia 2
CH - Svizzera 2
CR - Costa Rica 2
EU - Europa 2
GR - Grecia 2
IE - Irlanda 2
KZ - Kazakistan 2
MA - Marocco 2
MD - Moldavia 2
PH - Filippine 2
PY - Paraguay 2
VE - Venezuela 2
AL - Albania 1
BH - Bahrain 1
BM - Bermuda 1
BY - Bielorussia 1
CG - Congo 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
ET - Etiopia 1
GL - Groenlandia 1
HR - Croazia 1
IR - Iran 1
JO - Giordania 1
KH - Cambogia 1
LV - Lettonia 1
MC - Monaco 1
MK - Macedonia 1
MT - Malta 1
MU - Mauritius 1
MY - Malesia 1
NP - Nepal 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
PT - Portogallo 1
QA - Qatar 1
RO - Romania 1
TT - Trinidad e Tobago 1
Totale 8.377
Città #
Helsinki 1.884
Dallas 761
Ashburn 371
Singapore 288
Fairfield 279
Woodbridge 268
Warsaw 160
San Jose 153
Houston 140
Ann Arbor 135
Beijing 132
Wilmington 117
Santa Clara 113
Chandler 112
Hong Kong 106
Jacksonville 102
Seattle 102
Cambridge 91
Ferrara 86
Munich 67
New York 59
Los Angeles 55
Ho Chi Minh City 48
Hanoi 47
Izmir 38
Shanghai 33
Nanjing 32
Council Bluffs 28
Dong Ket 28
Milan 25
Boardman 24
Princeton 24
São Paulo 23
Turku 23
Brussels 21
Lauterbourg 21
Orem 21
Tokyo 20
Montreal 17
San Diego 17
Buffalo 13
Toronto 13
Shenyang 12
Amsterdam 11
Frankfurt am Main 11
Baghdad 10
Chicago 10
Denver 10
London 10
Phoenix 10
Stockholm 10
Atlanta 9
Changsha 9
Brasília 8
Da Nang 8
Hebei 8
Jiaxing 8
Mexico City 8
Mumbai 8
Redwood City 8
Tianjin 8
Addison 7
Ankara 7
Bremen 7
Brooklyn 7
Guangzhou 7
Haiphong 7
Johannesburg 7
Mcallen 7
Poplar 7
Des Moines 6
Hefei 6
Hải Dương 6
Jakarta 6
Montréal 6
Nanchang 6
Rome 6
Auburn Hills 5
Belo Horizonte 5
Biên Hòa 5
Brno 5
Chennai 5
Curitiba 5
Falls Church 5
Montevideo 5
Moscow 5
Querétaro 5
San Mateo 5
Tashkent 5
Thái Nguyên 5
Zhengzhou 5
Bari 4
Boston 4
Cagliari 4
Cotia 4
Guarulhos 4
Istanbul 4
Jinan 4
Manchester 4
Mountain View 4
Totale 6.484
Nome #
1,3-Dipropyl-8-(1-phenylacetamide-1H-pyrazol-3-yl)-xanthine derivatives as highly potent and selective human A2B adenosine receptor antagonists 3.103
Design and Synthesis of New A2A and A3 Adenosine Receptors Antagonists 395
Synthesis and Structure Activity Relationship Investigation of Triazolo[1,5-a]pyrimidines as CB2 Cannabinoid Receptor Inverse Agonists 311
A3 adenosine receptor antagonists: History and future perspectives 289
Design, synthesis, and biological evaluation of novel 2-((2-(4-(substituted)phenylpiperazin-1-yl)ethyl)amino)-5'-N-ethylcarboxamidoadenosines as potent and selective agonists of the A2A adenosine receptor 281
7-Substituted-pyrrolo[3,2-d]pyrimidine-2,4-dione derivatives as antagonists of the transient receptor potential ankyrin 1 (TRPA1) channel: A promising approach for treating pain and inflammation 263
7-Oxo-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxamides as Selective CB2 Cannabinoid Receptor Ligands: Structural Investigations around a Novel Class of Full Agonists 254
New 2-heterocyclyl-imidazo[2,1- i ]purin-5-one derivatives as potent and selective human A 3 adenosine receptor antagonists 247
N-6-[(Hetero)aryl/(cyclo)alkyl-carbamoyi-methoxy-phenyl]-(2chloro)-5 '-N-ethylearboxamido-adenosines: The first example of adenosine-related structures with potent agonist activity at the human A(2B) adenosine receptor 246
One-pot reaction to obtain N,N'-disubstituted guanidines of pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidine scaffold as human A3 adenosine receptor antagonists 231
Pyrazole phenylcyclohexylcarbamates as inhibitors of human fatty acid amide hydrolases (FAAH) 228
Structure-activity relationship studies of a new series of imidazo[2,1-f] purinones as potent and selective A3 adenosine receptor antagonists 215
Synthesis and Biological Evaluation of Novel Allosteric Enhancers of the A1 Adenosine Receptor Based on 2-Amino-3-(4’-Chlorobenzoyl)-4-Substituted-5-Arylethynyl Thiophene 207
Water-Soluble Pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidines as Human A3 Adenosine Receptor Antagonists 205
Antinociceptive effects of the selective CB2 agonist MT178 in inflammatory and chronic rodent pain models. 157
Mortality from cancer in people with severe mental disorders in Emilia Romagna Region, Italy 145
Novel 1,3-Dipropyl-8-(3-benzimidazol-2-yl-methoxy-1-methylpyrazol-5-yl)xanthines as Potent and Selective A2B Adenosine Receptor Antagonists 140
Discovery of 7-oxopyrazolo[1,5-a]pyrimidine-6-carboxamides as potent and selective CB(2) cannabinoid receptor inverse agonists. 133
Pyrrolo- and pyrazolo-[3,4-e][1,2,4]triazolo[1,5-c]pyrimidines as adenosine receptor antagonists 130
Design, Synthesis, and Pharmacological Properties of New Heteroarylpyridine/Heteroarylpyrimidine Derivatives as CB2 Cannabinoid Receptor Partial Agonists 125
Synthesis and Biological Evaluation of Pyrazolo[3,4-b]pyridin-4-ones as a New Class of Topoisomerase II Inhibitors 125
null 124
null 121
null 118
null 107
null 103
null 96
Synthesis and Biological Evaluation of Novel 2-Amino-3-Aroyl-4-Neopentyl-5-Substituted Thiophene Derivatives as Allosteric Enhancers of the A1 Adenosine Receptor 95
null 84
null 83
Transient receptor potential ankyrin 1 (TRPA1) antagonists 71
Totale 8.432
Categoria #
all - tutte 24.441
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.077
Totale 25.518


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022321 20 17 31 15 28 18 15 15 22 33 23 84
2022/2023286 29 37 4 39 37 40 22 16 37 1 12 12
2023/2024216 17 16 8 5 22 42 6 33 2 6 5 54
2024/2025773 23 42 63 39 72 77 53 47 95 46 109 107
2025/20264.528 211 261 708 256 304 154 208 101 2.016 195 90 24
2026/2027137 137 0 0 0 0 0 0 0 0 0 0 0
Totale 8.432